TY - JOUR
T1 - Sequence variation in group A Streptococcus pili and association of pilus backbone types with lancefield T serotypes
AU - Falugi, Fabiana
AU - Zingaretti, Chiara
AU - Pinto, Vittoria
AU - Mariani, Massimo
AU - Amodeo, Laura
AU - Manetti, Andrea G.O.
AU - Capo, Sabrina
AU - Musser, James M.
AU - Orefici, Graziella
AU - Margarit, Immaculada
AU - Telford, John L.
AU - Grandi, Guido
AU - Mora, Marirosa
N1 - Funding Information:
Received 10 April 2008; accepted 8 July 2008; electronically published 17 October 2008. Potential conflicts of interest: G.G., J.L.T., and I.M. are employed by Novartis Vaccines and hold company stock options. All other authors report no potential conflicts. Financial support: Novartis Vaccines and Diagnostics; National Institutes of Health (grant 5 U01 A1060595-04); Italian Ministry of University and Scientific and Technological Research (MURST 10911). a These authors contributed equally to the work. b Present affiliation: Fondazione Istituto Nazionale Genetica Molecolare, Milano, Italy. Reprints or correspondence: Guido Grandi, Novartis Vaccines, Siena, Italy, Via Fiorentina 1, 53100 Siena, Italy (guido.grandi@novartis.com).
PY - 2008/12/15
Y1 - 2008/12/15
N2 - Background. We previously reported that group A Streptococcus (GAS) pili are the T antigens described by Rebecca Lancefield. We also showed that these pili, constituted by backbone, ancillary 1, and ancillary 2 proteins, confer protection against GAS challenge in a mouse model. Methods. We evaluated pilus distribution and conservation by sequencing the subunits of 39 new GAS isolates and used immunoblot analysis and agglutination assays to define the specificity of T sera to pilus subunits. Results. GAS pili are encoded by 9 different islands within which backbone protein, ancillary protein 1, and ancillary protein 2 cluster in 15, 16, and 5 variants, respectively. Immunoblot and agglutination assays revealed that T type is determined by the backbone variant. This observation enabled us to set up a simple polymerase chain reaction assay to define the T type of GAS isolates. Conclusions. We propose the use of a tee gene sequence typing, analogous to the emm gene typing, as a valuable molecular tool that could substitute for the serological T classification of GAS strains. From our sequence analysis and from recent epidemiological data, we estimate that a vaccine comprising a combination of 12 backbone variants would protect against >90% of currently circulating strains.
AB - Background. We previously reported that group A Streptococcus (GAS) pili are the T antigens described by Rebecca Lancefield. We also showed that these pili, constituted by backbone, ancillary 1, and ancillary 2 proteins, confer protection against GAS challenge in a mouse model. Methods. We evaluated pilus distribution and conservation by sequencing the subunits of 39 new GAS isolates and used immunoblot analysis and agglutination assays to define the specificity of T sera to pilus subunits. Results. GAS pili are encoded by 9 different islands within which backbone protein, ancillary protein 1, and ancillary protein 2 cluster in 15, 16, and 5 variants, respectively. Immunoblot and agglutination assays revealed that T type is determined by the backbone variant. This observation enabled us to set up a simple polymerase chain reaction assay to define the T type of GAS isolates. Conclusions. We propose the use of a tee gene sequence typing, analogous to the emm gene typing, as a valuable molecular tool that could substitute for the serological T classification of GAS strains. From our sequence analysis and from recent epidemiological data, we estimate that a vaccine comprising a combination of 12 backbone variants would protect against >90% of currently circulating strains.
UR - http://www.scopus.com/inward/record.url?scp=56749155689&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=56749155689&partnerID=8YFLogxK
U2 - 10.1086/593176
DO - 10.1086/593176
M3 - Article
C2 - 18928376
AN - SCOPUS:56749155689
VL - 198
SP - 1834
EP - 1841
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
SN - 0022-1899
IS - 12
ER -